| Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi, A Sboner, V Sailer, ... Cancer discovery 7 (5), 462-477, 2017 | 939 | 2017 |
| Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis V Ramaswamy, M Remke, E Bouffet, CC Faria, S Perreault, YJ Cho, ... The lancet oncology 14 (12), 1200-1207, 2013 | 416 | 2013 |
| Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide J Triscott, C Lee, K Hu, A Fotovati, R Berns, M Pambid, M Luk, RE Kast, ... Oncotarget 3 (10), 1112, 2012 | 157 | 2012 |
| Personalizing the treatment of pediatric medulloblastoma: polo-like kinase 1 as a molecular target in high-risk children J Triscott, C Lee, C Foster, B Manoranjan, MR Pambid, R Berns, ... Cancer research 73 (22), 6734-6744, 2013 | 111 | 2013 |
| YB-1 bridges neural stem cells and brain tumor–initiating cells via its roles in differentiation and cell growth A Fotovati, S Abu-Ali, PS Wang, LP Deleyrolle, C Lee, J Triscott, JY Chen, ... Cancer research 71 (16), 5569-5578, 2011 | 108 | 2011 |
| Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice C Lee, A Fotovati, J Triscott, J Chen, C Venugopal, A Singhal, C Dunham, ... Stem cells 30 (6), 1064-1075, 2012 | 96 | 2012 |
| Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram J Triscott, M Rose Pambid, SE Dunn Stem cells 33 (4), 1042-1046, 2015 | 80 | 2015 |
| FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells B Manoranjan, X Wang, RM Hallett, C Venugopal, SC Mack, N McFarlane, ... Stem cells 31 (7), 1266-1277, 2013 | 77 | 2013 |
| Personalized In vitro and C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi, A Sboner, V Sailer, ... Vivo Cancer Models to Guide Precision Medicine, In: Cancer Discov. 2017; 7 …, 2017 | 62 | 2017 |
| Beyond PI3Ks: targeting phosphoinositide kinases in disease JE Burke, J Triscott, BM Emerling, GRV Hammond Nature Reviews Drug Discovery 22 (5), 357-386, 2023 | 56 | 2023 |
| Overcoming resistance to Sonic Hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma MR Pambid, R Berns, HH Adomat, K Hu, J Triscott, N Maurer, N Zisman, ... Pediatric blood & cancer 61 (1), 107-115, 2014 | 53 | 2014 |
| PI5P4Ks drive metabolic homeostasis through peroxisome-mitochondria interplay A Ravi, L Palamiuc, RM Loughran, J Triscott, GK Arora, A Kumar, V Tieu, ... Developmental cell 56 (11), 1661-1676. e10, 2021 | 29 | 2021 |
| Deep Sequencing Identifies IDH1 R132S Mutation in Adult Medulloblastoma M Snuderl, J Triscott, PA Northcott, HA Shih, E Kong, H Robinson, ... Journal of Clinical Oncology 33 (6), e27-e31, 2015 | 22 | 2015 |
| PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition J Triscott, M Reist, L Küng, FC Mosele, M Lehner, J Gallon, A Ravi, ... Science advances 9 (5), eade8641, 2023 | 15 | 2023 |
| Prostate Power Play: Does Pik3ca Accelerate Pten-Deficient Cancer Progression? J Triscott, MA Rubin Cancer discovery 8 (6), 682-685, 2018 | 13 | 2018 |
| Biology LL Chee Pelangi Publishing Group Bhd, 1969 | 13 | 1969 |
| Clinically tractable outcome prediction of non-WNT/non-SHH medulloblastoma based on TPD52 IHC in a multicohort study A Delaidelli, C Dunham, M Santi, GL Negri, J Triscott, O Zheludkova, ... Clinical Cancer Research 28 (1), 116-128, 2022 | 10 | 2022 |
| Minor intron splicing is critical for survival of lethal prostate cancer A Augspach, KD Drake, L Roma, E Qian, SR Lee, D Clarke, S Kumar, ... Molecular cell 83 (12), 1983-2002. e11, 2023 | 8 | 2023 |
| Outcomes of a radiation sparing approach in medulloblastoma by subgroup in young children: an institutional review R Ronsley, J Triscott, J Stanek, SR Rassekh, A Lum, S Cheng, K Goddard, ... Child's nervous system 39 (8), 2095-2104, 2023 | 4 | 2023 |
| Minor intron splicing efficiency increases with the development of lethal prostate cancer A Augspach, KD Drake, L Roma, E Qian, SR Lee, D Clarke, S Kumar, ... bioRxiv, 2021.12. 09.471104, 2021 | 4 | 2021 |
